Feasibility, safety and tolerability of intradialytic creatine supplementation in hemodialysis: A double-blind, randomized, placebo-controlled pilot study
Caecilia S E Doorenbos, Yvonne van der Veen, Adrian Post, Jip Jonker, Tim J Knobbe, Daan Kremer, Dion Groothof, M Rebecca Heiner-Fokkema · 2026
Read Feasibility, safety and tolerability of intradialytic creatine supplementation in hemodialysis: A double-blind, randomized, placebo-controlled pilot study by Caecilia S E Doorenbos, Yvonne van der Veen, Adrian Post, Jip Jonker, Tim J Knobbe, Daan Kremer, Dion Groothof, M Rebecca Heiner-Fokkema (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0354883.txt.
Description
Caecilia Doorenbos and colleagues run in 2026 a small blinded pilot on adding creatine, a muscle energy compound, directly into dialysis fluid for kidney patients. Dialysis patients often run low on creatine, which links to worse life quality and survival. Groups received rising doses in the fluid over six weeks, with some receiving a dummy fluid instead.
Treatment was mostly well tolerated, with no serious harmful events and one dropout tied to a possible side effect. Creatine levels in red cells and blood plasma rose with dose compared with dummy treatment. The pilot supports a larger trial to test whether raising levels improves health.
Catalog record
| CREATOR | Caecilia S E Doorenbos, Yvonne van der Veen, Adrian Post, Jip Jonker, Tim J Knobbe, Daan Kremer, Dion Groothof, M Rebecca Heiner-Fokkema |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47329 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |